4978.T Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 09:00):

Stats
Dzisiejszy wolumen	477 600
Średni wolumen	523 373
Kapitalizacja rynkowa	12.43B
EPS	¥0 ( 2024-02-08 )
Następna data zysków	( ¥-3.62 ) 2024-05-10
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-53.67
ATR14	¥0.308 (0.22%)

Wolumen Korelacja

Długi: 0.11 (neutral)

Krótki: -0.33 (neutral)

Signal:(57.133) Neutral

ReproCELL Incorporated Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ReproCELL Incorporated Korelacja - Waluta/Towar

-0.78
( moderate negative )

-0.66
( moderate negative )

-0.18
( neutral )

-0.26
( neutral )

-0.63
( weak negative )

ReproCELL Incorporated Finanse

Annual	2022
Przychody:	¥2.95B
Zysk brutto:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
Przychody:	¥2.95B
Zysk brutto:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
Przychody:	¥2.23B
Zysk brutto:	¥803.44M (35.96 %)
EPS:	¥-7.57

FY	2021
Przychody:	¥1.29B
Zysk brutto:	¥482.70M (37.53 %)
EPS:	¥-11.38

Financial Reports:

No articles found.

ReproCELL Incorporated

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

Aktualne aktualizacje dla ReproCELL Incorporated [4978.T]

Upcoming Earnings Alert